Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
Breast Cancer Research and Treatment
|
January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?
G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Oncogene
|
March 14, 2000
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
R D Cardiff, M R Anver, B A Gusterson, et al.
Annals of Surgical Oncology
|
January 10, 2009
Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter
Carla J Christy, David Thorsteinsson, Baiba J Grube, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
July 23, 2008
Breast sentinel lymph node dissection before preoperative chemotherapy
Baiba J Grube, Carla J Christy, Dalliah Black, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201)
Karim El-Sahwi, Stefania Bellone, Emiliano Cocco, et al.
British Journal of Cancer
|
November 19, 2009
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
K El-Sahwi, S Bellone, E Cocco, et al.
British Journal of Cancer
|
June 19, 2009
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
E Cocco, S Bellone, K El-Sahwi, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
Breast Cancer Research and Treatment
|
January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?
G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Oncogene
|
March 14, 2000
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
R D Cardiff, M R Anver, B A Gusterson, et al.
Annals of Surgical Oncology
|
January 10, 2009
Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter
Carla J Christy, David Thorsteinsson, Baiba J Grube, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
July 23, 2008
Breast sentinel lymph node dissection before preoperative chemotherapy
Baiba J Grube, Carla J Christy, Dalliah Black, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201)
Karim El-Sahwi, Stefania Bellone, Emiliano Cocco, et al.
British Journal of Cancer
|
November 19, 2009
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
K El-Sahwi, S Bellone, E Cocco, et al.
British Journal of Cancer
|
June 19, 2009
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
E Cocco, S Bellone, K El-Sahwi, et al.
Page
of 19